
Explain drug concentration over time, define the therapeutic window, and cover population-based dosing while detailing the right patient, drug, dose, route, time, reason, documentation, and response.
Explain how ACE inhibitors and ARBs block the renin-angiotensin system to lower blood pressure through vasodilation, while noting dry cough and angioedema risks and the need for renal monitoring.
Explore calcium channel blockers and beta blockers, their dihydrobyrudine vs non-dihydrobyrudine classifications, vascular vs cardiac effects, heart failure safety, and key side effects and safety cautions.
Explore diuretics by class: thiazides, loop, potassium-sparing, carbonic anhydrase inhibitors, osmotic, and aldosterone antagonists—covering indications, key side effects, and safe combinations with ACE inhibitors and ARBs.
Explore warfarin's dosing, monitoring, bleeding risks, and bridging with inoxaparin, alongside direct oral anticoagulants that offer rapid onset, no INR monitoring, and factor Xa or thrombin inhibition.
Vancomycin treats MRSA and Clostridium difficile infection with IV 15–20 mg/kg every 8–12 hours and oral 1–5 mg four times daily, with renal dose adjustment and therapeutic drug monitoring.
Describe fluconazole as first-line therapy for candidiasis, covering vaginal, oropharyngeal, systemic uses, dosing, and CYP interactions; note terbinafine's topical and oral use for dermatophyte infections and liver monitoring.
Compare typical and atypical antipsychotics, noting haloperidol and risperidone and their dose ranges. Monitor for extrapyramidal symptoms, QTc prolongation, metabolic side effects, and rare events like neuroleptic malignant syndrome.
Identify indications and key clinical points for antiepileptics, including valproate, carbamazepine, phenytoin, and levetiracetam, for epilepsy, neuropathic pain, bipolar disorder, and migraine prophylaxis, including not stopping abruptly.
Explore asthma management with reliever and controller therapies, including SABA like salbutamol, inhaled corticosteroids, ICS-LABA combos, and strategies like AIR and MART to optimize maintenance and relief.
Explore COPD management with LABA, LAMA, LABA-LAMA, and ICS, plus roflumilast for severe cases; emphasize smoking cessation, vaccination, and rehabilitation per GOAT guidelines.
Master dyspepsia relief with alginate antacids and ppi therapy, note two-hour spacing for drug interactions and pregnancy safety, then treat threadworms with mebendazole and household-wide deworming.
This extensive professional development course is meticulously designed to bridge the gap between theoretical pharmacology and the high-stakes reality of bedside clinical practice. In today’s rapidly evolving medical landscape, healthcare professionals must do more than just memorise drug names; they must master the nuance of pharmacodynamics (what the drug does to the body) and pharmacokinetics (what the body does to the drug) to provide truly patient-centred care.
Core Therapeutic Domains
The curriculum provides an exhaustive exploration of the primary therapeutic pillars encountered in modern medicine:
Cardiovascular & Renal: Management of hypertension, heart failure, and anticoagulation.
Anti-infectives: Navigating antibiotic stewardship, resistance patterns, and antiviral protocols.
Endocrine & Metabolic: Advanced insights into insulin titration, thyroid regulation, and bone health.
Neurology & Mental Health: Understanding the delicate balance of CNS medications, from analgesics to psychotropic therapies.
Critical Care & High-Risk Meds: Specialised focus on "Look-Alike, Sound-Alike" (LASA) drugs and narrow therapeutic index medications.
Bridging Theory and Practice
Beyond basic drug action, this course emphasises medication safety and the mitigation of adverse drug reactions (ADRs). You will engage with complex case studies that require sharp clinical reasoning and evidence-based decision-making. By analysing real-world scenarios, you will learn to identify potential contraindications and drug-drug interactions before they reach the patient.
Professional Impact
Whether you are a pharmacy student, a junior clinician, or an experienced practitioner refreshing your knowledge, this programme empowers you to lead with confidence. You will refine your skills in interdisciplinary communication, ensuring that you can advocate for patient safety within a medical team. Ultimately, this course is about more than just knowledge—it is about enhancing your professional competence to ensure the best possible patient outcomes in both hospital and community settings.